We are an NYC based biotechnology start up that specializes in the isolation and development of therapeutic human monoclonal antibodies for treating infectious diseases.

 

Infectious diseases are the leading cause of deaths worldwide due the emergence of novel pathogens and the reemergence of drug resistant pathogens. Because of this there is a growing need to develop novel therapeutics against infectious diseases. Antibodies represent a highly effective and safe way to treat and cure infectious diseases.

 

Our Portfolio

Hanta Virus Control (Preclinical)85
HP Erradication (Preclinical)50
HIV Therapies (Preclinical) 35